Related Experiment Videos
Drug-specific Fab therapy in drug overdose
Archives of Pathology & Laboratory Medicine
|August 1, 1987
Summary
Digoxin-specific antibody fragments (Fab) are a preferred treatment for severe digitalis intoxication. This drug-specific therapy shows promise for treating overdoses of other medications as well.
Area of Science:
- Pharmacology
- Toxicology
- Immunology
Background:
- Severe digitalis intoxication is a life-threatening condition.
- Digoxin-specific antibody fragments (Fab) have emerged as a primary treatment.
- The application of Fab technology extends beyond digoxin.
Purpose of the Study:
- To review the efficacy of digoxin-specific Fab fragments in treating digitalis intoxication.
- To explore the potential of Fab technology for treating overdoses of other drugs.
- To discuss advancements in laboratory methods for monitoring Fab therapy.
Main Methods:
- Review of existing literature on digoxin-specific Fab therapy.
- Examination of studies involving Fab fragments for desipramine and phencyclidine toxicity.
- Analysis of evolving laboratory techniques for therapeutic drug monitoring.
Main Results:
- Digoxin-specific Fab fragments are increasingly recognized as a treatment of choice for severe digitalis intoxication.
- Preliminary studies suggest Fab technology's applicability to other drug classes, including desipramine and phencyclidine.
- Advancements in Fab technology are paralleled by improvements in monitoring treatment efficacy.
Conclusions:
- Digoxin-specific Fab fragments represent a significant advancement in managing digitalis toxicity.
- The drug-specific Fab approach holds potential for broader applications in toxicology.
- Continued development in Fab technology and associated laboratory methods is crucial for optimizing antidotal therapies.